This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Kurt Gefft | |
|---|---|
| Name | Kurt Gefft |
| Birth date | 1951 |
| Birth place | Vienna, Austria |
| Nationality | Austrian |
| Occupation | Biochemist |
| Known for | Protein folding, chaperone research |
| Awards | Marcel Benoist Prize, Louis-Jeantet Prize |
Kurt Gefft was an Austrian-born biochemist and molecular biologist notable for pioneering studies of protein folding, molecular chaperones, and cellular quality-control pathways. Over a career spanning universities and research institutes across Europe and North America, he combined biochemical, structural, and cellular approaches to elucidate mechanisms that link protein homeostasis to human disease. Gefft's work influenced investigations in cell biology, neurodegeneration, and biotechnology.
Gefft was born in Vienna and educated in Austria and Germany, completing secondary studies in Vienna before undertaking undergraduate training at the University of Vienna and the Technical University of Munich. He pursued doctoral studies at the Max Planck Institute for Biochemistry under mentors associated with the institute's traditions in enzymology and structural biology. Postdoctoral training included fellowships at the European Molecular Biology Laboratory (EMBL) and a research period at the University of Cambridge, where he worked alongside groups focused on protein structure, folding, and molecular chaperones.
Gefft held faculty and research positions at the University of Vienna, the Max Planck Institute, the European Molecular Biology Laboratory, the University of Cambridge, and Columbia University during his career. He directed a laboratory that bridged departments of biochemistry, molecular biology, and cell biology, collaborating with colleagues at Harvard Medical School, the Massachusetts Institute of Technology, the Salk Institute, and the Karolinska Institute. Gefft served on advisory boards for the Wellcome Trust, the Howard Hughes Medical Institute, the European Research Council, and national research councils in Austria and Germany. He was a visiting professor at the California Institute of Technology and a member of editorial boards for journals linked to the Royal Society, Cell Press, and Nature Portfolio.
Gefft's research program addressed protein folding pathways, the action of molecular chaperones such as Hsp70 and GroEL/GroES, and endoplasmic reticulum-associated degradation (ERAD). He combined biochemical reconstitution, X-ray crystallography, cryo-electron microscopy, and live-cell imaging techniques developed in laboratories at EMBL and the Max Planck Society. His laboratory provided mechanistic models for co-translational folding on ribosomes, building on concepts from groups at Cold Spring Harbor Laboratory, the University of California, San Francisco, and Johns Hopkins University. Gefft characterized interactions between chaperones and nascent polypeptides, contributing to understanding of proteostasis networks studied at the Broad Institute, the Whitehead Institute, and the Francis Crick Institute.
Gefft also investigated the role of misfolded proteins in neurodegenerative conditions, connecting molecular findings to pathological features described by researchers at the Mayo Clinic, the National Institutes of Health, and University College London. He collaborated with scientists at the Institut Pasteur, the Max Delbrück Center, and Imperial College London to explore small-molecule modulators of protein quality-control pathways, intersecting with translational programs at Genentech, Novartis, and Pfizer. His structural work paralleled advances from the European Synchrotron Radiation Facility, the Diamond Light Source, and the National Center for Electron Microscopy.
Gefft received national and international recognition, including the Marcel Benoist Prize, the Louis-Jeantet Foundation Prize, and election to academies such as the Austrian Academy of Sciences and the European Molecular Biology Organization (EMBO). He was awarded honorary doctorates by institutions associated with the University of Cambridge and the University of Oxford consortia and received research grants from the European Research Council and the Wellcome Trust. Gefft lectured in named series at the Royal Society, the Royal Institution, and the Howard Hughes Medical Institute symposia.
Gefft maintained connections with musical and cultural institutions in Vienna, collaborating with colleagues from the Vienna Philharmonic and the Burgtheater on outreach activities. He was married to a clinical neurologist affiliated with the University Hospital Vienna and had family ties that included researchers at the Karolinska Institute and the Max Planck Society. Outside the laboratory, Gefft was active in science policy dialogues convened by the European Commission and UNESCO and participated in public lectures at institutions such as the Library of Congress and the Smithsonian Institution.
Gefft's legacy rests on mechanistic frameworks for how molecular chaperones direct folding, how cells triage misfolded proteins through ERAD and autophagy, and how perturbations of proteostasis contribute to disease. His interdisciplinary approach fostered collaborations between structural biology, cell biology, and clinical neuroscience, influencing research agendas at institutions including Cold Spring Harbor Laboratory, the Scripps Research Institute, and the Max Planck Institutes. Trainees from his laboratory went on to lead groups at Harvard University, Princeton University, the University of California system, and the ETH Zurich, propagating his methodologies and conceptual advances. Gefft's work continues to inform therapeutic strategies pursued by biotech companies and academic translational centers addressing neurodegeneration, protein misfolding disorders, and proteostasis-based interventions.
Vienna University of Vienna Technical University of Munich Max Planck Institute for Biochemistry European Molecular Biology Laboratory University of Cambridge Harvard Medical School Massachusetts Institute of Technology Salk Institute Karolinska Institute Wellcome Trust Howard Hughes Medical Institute European Research Council California Institute of Technology Royal Society Cell Press Nature (journal) EMBO Hsp70 GroEL GroES endoplasmic reticulum-associated degradation Cold Spring Harbor Laboratory University of California, San Francisco Johns Hopkins University Broad Institute Whitehead Institute Francis Crick Institute Mayo Clinic National Institutes of Health University College London Institut Pasteur Max Delbrück Center for Molecular Medicine Imperial College London Genentech Novartis Pfizer European Synchrotron Radiation Facility Diamond Light Source National Center for Electron Microscopy Marcel Benoist Prize Louis-Jeantet Prize Austrian Academy of Sciences University of Oxford Royal Institution Howard Hughes Medical Institute symposia Vienna Philharmonic Burgtheater University Hospital Vienna European Commission UNESCO Library of Congress Smithsonian Institution Cold Spring Harbor Laboratory Scripps Research Institute Max Planck Society Harvard University Princeton University University of California ETH Zurich biotechnology neurodegeneration proteostasis autophagy protein folding structural biology cell biology clinical neuroscience translational research biotech companies academic translational centers protein misfolding disorders
Category:Austrian biochemists